TARO PHARMACEUTICAL INDUS (TARO) Stock Analyst Ratings
USA - NYSE:TARO - IL0010827181 - Common Stock
42.97 USD
0 (0%)
42.97 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 43% to TARO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 43.86. This target is 2.07% above the current price.
TARO was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about TARO.
In the previous month the buy percentage consensus was at a similar level.
TARO was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-01-18 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-01-25 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-01-31 | HC Wainwright & Co. | Maintains | Buy |
| 2022-01-18 | HC Wainwright & Co. | Maintains | Buy |
| 2021-07-28 | HC Wainwright & Co. | Maintains | Buy |
| 2021-06-02 | HC Wainwright & Co. | Maintains | Buy |
TARO PHARMACEUTICAL INDUS / TARO FAQ
Can you provide the average price target for TARO PHARMACEUTICAL INDUS stock?
6 analysts have analysed TARO and the average price target is 43.86 USD. This implies a price increase of 2.07% is expected in the next year compared to the current price of 42.97.
How do analysts rate TARO PHARMACEUTICAL INDUS (TARO)?
The consensus rating for TARO PHARMACEUTICAL INDUS (TARO) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.